PraderWilli syndrome (PWS) is a genetic disorder due to loss of function of specific genes. In newborns symptoms include weak muscles, poor feeding, and slow development. Beginning in childhood the person becomes constantly hungry which often leads to obesity and type 2 diabetes.
This report elaborates the market size, market characteristics, and market growth of the Prader-Willi Syndrome (PWS) Therapeutics industry, and breaks down according to the type, application, and consumption area of Prader-Willi Syndrome (PWS) Therapeutics. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Prader-Willi Syndrome (PWS) Therapeutics in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Prader-Willi Syndrome (PWS) Therapeutics market covered in Chapter 13:
LG Life Sciences, Ltd.
Ferring International Center S.A.
Essentialis, Inc.
Zafgen Inc
Soleno Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp.
Insys Therapeutics Inc
Millendo Therapeutics Inc
Saniona AB
Pfizer Inc.
P2D Bioscience
OptiNose US Inc
Rhythm Pharmaceuticals

In Chapter 6, on the basis of types, the Prader-Willi Syndrome (PWS) Therapeutics market from 2015 to 2025 is primarily split into:
Betahistine Hydrochloride
Diazoxide Choline CR
FE-992097
NOX-B11
Others

In Chapter 7, on the basis of applications, the Prader-Willi Syndrome (PWS) Therapeutics market from 2015 to 2025 covers:
Clinic
Hospital
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025